Literature DB >> 8288709

Hyperuricemia and insulin resistance.

H Vuorinen-Markkola, H Yki-Järvinen.   

Abstract

The associates of gout-obesity, hypertriglyceridemia, glucose intolerance, and hypertension, strikingly resemble those of insulin resistance. In the present study we determined whether hyperuricemia is associated with insulin resistance and, if so, whether this association can be explained by other components of the syndrome. For this purpose we quantitated insulin sensitivity (euglycemic clamp) in 37 nondiabetic subjects (aged 30-68 yr) exhibiting varying degrees of the metabolic syndrome (body mass index, 21.5-35.7 kg/m2; serum triglycerides, 0.4-22.0 mmol/L; high density lipoprotein cholesterol 0.38-1.86 mmol/L; blood pressure, 190-100/116-60 mm Hg). In simple linear regression analysis, the serum uric acid concentration (range, 182-568 mumol/L) was inversely correlated with insulin sensitivity (rate of glucose utilization; r = -0.61; P < 0.001) and positively with serum triglycerides (r = 0.68; P < 0.001), but not with body mass index, age, or the plasma glucose concentration. In multiple linear regression analysis, both insulin sensitivity (P < 0.05) and serum triglycerides (P < 0.005) were independently associated with the serum uric acid concentration, and together explained 50% of its variation. Addition of body mass index or age to the model did not improve the degree of explanation. Acute elevation of serum triglycerides about 3-fold, of plasma FFA about 9-fold, or of serum insulin about 28-fold had no effect on the serum uric acid concentration in healthy volunteers. The data indicate that hyperuricemia is indeed an inherent component of the metabolic syndrome and could also be used as a simple marker of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8288709     DOI: 10.1210/jcem.78.1.8288709

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  68 in total

1.  Metabolic syndrome in Tunisian bipolar I patients.

Authors:  A Ezzaher; Mouhamed D Haj; A Mechri; F Neffati; W Douki; L Gaha; M F Najjar
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

2.  Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study.

Authors:  Wolfgang Rathmann; Burkhard Haastert; Andrea Icks; Guido Giani; Jeffrey M Roseman
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 8.082

3.  Association of incident gout and mortality in dialysis patients.

Authors:  Scott D Cohen; Paul L Kimmel; Robert Neff; Lawrence Agodoa; Kevin C Abbott
Journal:  J Am Soc Nephrol       Date:  2008-05-28       Impact factor: 10.121

Review 4.  Fructose and uric acid in diabetic nephropathy.

Authors:  Petter Bjornstad; Miguel A Lanaspa; Takuji Ishimoto; Tomoki Kosugi; Shinji Kume; Diana Jalal; David M Maahs; Janet K Snell-Bergeon; Richard J Johnson; Takahiko Nakagawa
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

5.  Hyperlipidaemia in hyperuricaemia and gout.

Authors:  B Emmerson
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

6.  Relation between fractional urate excretion and serum triglyceride concentrations.

Authors:  C P Quaratino; C Rucci; A Giacomello
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

7.  Obesity and younger age at gout onset in a community-based cohort.

Authors:  Mara A McAdams DeMarco; Janet W Maynard; Mary Margret Huizinga; Alan N Baer; Anna Köttgen; Allan C Gelber; Josef Coresh
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

8.  Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study.

Authors:  P H Dessein; E A Shipton; A E Stanwix; B I Joffe; J Ramokgadi
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

9.  Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.

Authors:  F Cardona; F J Tinahones; E Collantes; A Escudero; E García-Fuentes; F J Soriguer
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

10.  Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women.

Authors:  T Montalcini; G Gorgone; C Gazzaruso; G Sesti; F Perticone; A Pujia
Journal:  Intern Emerg Med       Date:  2007-03-31       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.